HOPE Act

H.R. 3043; S. 1710 - Labor HHS appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvent S. 1066 Medical Affordability Act H.R. 4854, S. 2041 False Claims Correction Act S. 484 Research Misconduct Clinical Trials

Client expense: $110,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

H.R. 3043; S. 1710 - Labor HHS appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvent S. 1066 Medical Affordability Act S. 484 Research Misconduct Clinical Trials

Client expense: $110,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

HR 2560 Human Cloning Prohibition Act of 2007 Amend Federal Food, Drug and Cosmetic Act to prohibit human cloning HR 2564 Human Cloning Prohibition Act of 2007 Amend Title 18, U.S. Code to prohibit human cloning S. 5 Stem Cell Research Enhancement Act of 2007 Overturn President's policy on funding embryonic stem cell research S. 30 HOPE Act Intensify research to derive human pluripotent stem cell lines S. 2358 Human Animal Hybrid Ban Ban on creating human animal hybrids HR 3 Stem Cell Research Enhancement Act of 2007 Overturn President's policy on funding of embryonic stem cell research S. 812 Human Cloning Ban and Stem Cell Research Protection Act of 2007 Ban human cloning but allow for embryonic stem cell research

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3043; S. 1710 - Labor HHS appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvent S. 1066 Medical Affordability Act S. 484 Research Misconduct Clinical Trials

Client expense: $160,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.

Client expense: $230,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)

Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.

Client expense: $230,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)

HR 3 Stem Cell Research Enhancement Act of 2007 S. 5 Stem Cell Research Enhancement Act of 2007 S. 30 HOPE Act

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 3 & S 5, Stem Cell Research Enhancement Act of 2007, all provisions S 30, Hope Offered Through Principled and Ethical Stem Cell Research Act (HOPE Act), all provisions

Client expense: Not reported · Firm income: $40,000

HR 3 & S 5, Stem Cell Research Enhancement Act of 2007, all provisions S 30, Hope Offered Through Principled and Ethical Stem Cell Research Act (HOPE Act), all provisions

Client expense: Not reported · Firm income: $40,000

HR 3/S 5 - Stem Cell Research Enhancement Act of 2007. S 30/HR 322 - Hope Offered through Principled and Ethical "HOPE" Stem Cell Research Act. S 558/HR 1424 - Mental Health Parity Act of 2007. S 1775 - No Child Left Behind Act of 2007 HR 976 - Children's Health Insurance Program Reauthorization Act of 2007 (Amend Title XXI of SSA) HR 3533 - Public Teaching Hospital Preservation Act. HR 3963 - Children's Health Insurance Program Reauthorization Act. HR 4105 - CMS Moratorium on Medicare Recovery Audit Contractor Program.

Client expense: $120,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, UNDETERMINED

Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Support ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.

Client expense: $418,305 · Firm income: Not reported

Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.

Client expense: $418,305 · Firm income: Not reported

H.R. 3043; S. 1710 - Labor HHS appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvent S. 1066 Medical Affordability Act S. 484 Research Misconduct Clinical Trials

Client expense: $80,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

HR 3 Stem Cell Research Enhancement Act of 2007 S. 5 Stem Cell Research Enhancement Act of 2007 S. 30 HOPE Act

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1893,Children's Health Insurance Program Reauthorization Act of 2007 H.R.2564/S.1036,Human Cloning Prohibition Act of 2007 S.812, Human Cloning Ban and Stem Cell Research Protection Act of 2007 S.30,Hope Offered through Principled and Ethical Stem Cell Research Act H.R.3/S.5,Stem Cell Research Enhancement Act of 2007 H.R.2762/S.1494, Reauthorization of the Special Statutory Funding Program for Type 1 Diabetes Research and the Special Diabetes Program for Indians H.R.3162,Children's Health and Medicare Protection Act of 2007

Client expense: $460,000 · Firm income: Not reported

Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Supported ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.

Client expense: $418,305 · Firm income: Not reported

Opposed bills to promote research that requires killing human embryos (HR 3, S. 5, S. 51). Opposed legislation to promote human clone-and-kill policy (HR 2560, S. 812). Support ban on human cloning (S. 1036, HR 2564). Supported bills to promote ethical forms of stem cell research (HR 322, HR 2807), and executive order to promote such research. Commented on draft language of S. 30; no objection to S. 30. Supported HR 1457 (post-abortion depression) and proposal to add comparable provisions to HR 20.

Client expense: $418,305 · Firm income: Not reported

S 3--Medicare Prescription Drug Price Negotiation Act of 2007, lowering cost of prescription drugs S 5--Stem Cell Research Enhancement Act of 2007, expansion of federal funding for stem cell research S 30--Alternative Stem Cell Research bill, expansion of federal funding for stem cell research, development of new cell lines S 446--Nurse Education, Expansion, and Development Act of 2007, nursing education programs enhancement HR 976--Small Business Tax Relief Act of 2007, reauthorization of the State Children's Health Insurance Program HR 3043, S 1710--FY2008 Labor/Health and Human Services/Education Appropriations bill, NIH research and training funding, CDC research and training funding, student financial aid HR 1944--Veterans Traumatic Brain Injury Treatment Act of 2007, identification of, research on, and treatment of traumatic brain injury

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 3 & S 5, Stem Cell Research Enhancement Act of 2007 S 30, Hope Offered Through Principled and Ethical Stem Cell Research Act (HOPE Act)

Client expense: Not reported · Firm income: $40,000

HR 3 & S 5, Stem Cell Research Enhancement Act of 2007 S 30, Hope Offered Through Principled and Ethical Stem Cell Research Act (HOPE Act)

Client expense: Not reported · Firm income: $40,000

S 30 - Hope Offered Through Principled and Ethical Stem Cell Research Act HR 1867 NSF Reauthorization S 761 - America Competes Act HR 2272 - 21st Century Competitiveness Act of 2007 HR 3, S 5 - Stem Cell Research Enhancement Act of 2007

Client expense: Not reported · Firm income: $60,000

HR3/S5 - Stem Cell Research Enhancement Act of 2007 S1277 – Critical Access to Clinical Lab Services Act of 2007 S30 - Hope Offered through Principled and Ethical Stem Cell Research Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Aeronautics & Space Administration (NASA), Natl Institutes of Health (NIH), Natl Oceanic & Atmospheric Administration (NOAA), Natl Science Foundation (NSF), SENATE, Veterans Affairs, Dept of (VA)